[Federal Register: October 26, 2005 (Volume 70, Number 206)]
[Page 61828-61829]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]



Food and Drug Administration

Vaccines and Related Biological Products Advisory Committee; 
Notice of Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.


    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). At least one 
portion of the meeting will be closed to the public.
    Name of Committee: Vaccines and Related Biological Products 
Advisory Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on November 16, 2005, from 
8:30 a.m. to 5:15 p.m. and on November 17, 2005, from 8:30 a.m. to 5:30 
    Location: Holiday Inn Select, 8120 Wisconsin Ave., Bethesda, MD.
    Contact Person: Christine Walsh or Denise Royster, Center for 
Biologics Evaluation and Research (HFM-71), Food and Drug 
Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, 
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 3014512391. Please call the 
Information Line for up-to-date information on this meeting.
    Agenda: On November 16, 2005, the committee will hear presentations 
and discuss the use of Madin-Darby Canine Kidney Cells for manufacture 
of Inactivated Influenza Vaccines. On November 17, 2005, the committee 
will discuss developing new Pneumococcal Vaccines for U.S. licensure 
for adults.
    Procedure: On November 16, 2005, from 8:30 a.m. to 5:15 p.m. and on 
November 17, 2005, from 10 a.m. to 5:30 p.m., the meeting is open to 
the public. Interested persons may present data, information, or views, 
orally or in writing, on issues pending before the committee. Written 
submissions may be made to the contact person by November 9, 2005. Oral 
presentations from the public will be scheduled on November 16, 2005, 
between approximately 1:45 p.m. and 2:15 p.m. and on November 17, 2005, 
between approximately 1 p.m. and 1:30 p.m. Time allotted for each 
presentation may be limited. Those desiring to make formal oral 
presentations should notify the contact person before November 9, 2005, 
and submit a brief statement of the general nature of the evidence or 
arguments they wish to present, the names and addresses of proposed 
participants, and an indication of the approximate time requested to 
make their presentation.
    Closed Committee Deliberations: On November 17, 2005, from 8:30 
a.m. to 9:55 a.m., the meeting will be closed to permit discussion and 
review of trade secret and/or confidential information (5 U.S.C. 
    Persons attending FDA's advisory committee meetings are advised 
that the

[[Page 61829]]

agency is not responsible for providing access to electrical outlets.
    FDA welcomes the attendance of the public at its advisory committee 
meetings and will make every effort to accommodate persons with 
physical disabilities or special needs. If you require special 
accommodations due to a disability, please contact Christine Walsh or 
Denise Royster at least 7 days in advance of the meeting.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: October 18, 2005.
Jason Brodsky,
Acting Associate Commissioner for External Relations.
[FR Doc. 05-21350 Filed 10-25-05; 8:45 am]